RA Capital funds buy $46.6 million of newly listed Bambusa shares

Two RA Capital funds bought about $46.6 million of Bambusa Therapeutics shares on October 30 and November 2, in a filing made public on November 3.

The purchases

1 insider
Purchase on Nov 2, filed on Nov 3
1
Buyer
$46.64M
Bought
0
Sellers

Director

RL
Ra Capital Management L.p.
Buy · $46.64M · 2,953,820 shares
On the right, by how much each one increased the number of shares they own. Purchases declared to the SEC, the US stock market watchdog (Form 4), decided on the spot and not scheduled in advance.

AI analysis

Nov 3
With TrueWallet Pro
Why these purchases matter given where the stock stands, and what they do not say. Upgrade to Pro from the TrueWallet app.

The whole feed is waiting

Sign in to read every post and follow wallets.
Sign in